BDBM50070207 CHEMBL3408038

SMILES CC[C@H](C)[C@H](NC(C)=O)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](Cc2cccc3ccccc23)NC(=O)CNC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2cn(C)c3ccccc23)NC(=O)[C@@H](NC1=O)C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(N)=O

InChI Key

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50070207   

TargetComplement C3(Homo sapiens (Human))
University Of California

Curated by ChEMBL
LigandPNGBDBM50070207(CHEMBL3408038)
Affinity DataIC50:  4.00E+3nMAssay Description:Inhibition of C3 cleavage in human serum assessed as reduction in C5b-9 formation compound preincubated for 15 mins measured 1 hr post LPS stimulatio...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetComplement C3(Homo sapiens (Human))
University Of California

Curated by ChEMBL
LigandPNGBDBM50070207(CHEMBL3408038)
Affinity DataIC50:  4.00E+3nMAssay Description:Inhibition of C3 cleavage in human serum assessed as reduction in C3b formation compound preincubated for 15 mins measured 1 hr post LPS stimulation ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed